Cargando…
Outer membrane vesicle vaccines for Neisseria gonorrhoeae
Multidrug-resistant Neisseria gonorrhoeae is a global health problem, and the development of a vaccine is considered essential for the effective control of gonorrhoea. The use of outer membrane vesicle vaccines to prevent N. gonorrhoeae infection has garnered considerable interest, and a recent stud...
Autores principales: | Semchenko, Evgeny A., Seib, Kate L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555735/ https://www.ncbi.nlm.nih.gov/pubmed/34716431 http://dx.doi.org/10.1038/s41585-021-00534-5 |
Ejemplares similares
-
The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae
por: Semchenko, Evgeny A, et al.
Publicado: (2019) -
The Neisseria gonorrhoeae Vaccine Candidate NHBA Elicits Antibodies That Are Bactericidal, Opsonophagocytic and That Reduce Gonococcal Adherence to Epithelial Cells
por: Semchenko, Evgeny A., et al.
Publicado: (2020) -
MetQ of Neisseria gonorrhoeae Is a Surface-Expressed Antigen That Elicits Bactericidal and Functional Blocking Antibodies
por: Semchenko, Evgeny A., et al.
Publicado: (2017) -
The Neisseria gonorrhoeae Methionine Sulfoxide Reductase (MsrA/B) Is a Surface Exposed, Immunogenic, Vaccine Candidate
por: Jen, Freda E.-C., et al.
Publicado: (2019) -
Intractable problems require novel solutions: it's time to get serious about developing a gonorrhoea vaccine
por: Semchenko, Evgeny A, et al.
Publicado: (2016)